UPCC 23217: A Phase 1b/2 Study ofBMS-813160 in Combination with Chemotherapy or Nivolumab in Patients with Advanced Solid Tumors
Brief description of study
TBD
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
['Colorectal Cancer', 'Pancreatic Cancer']
-
Age: - 99 Years
-
Gender: All
Updated on
30 Jan 2020.
Study ID: 828240
